Found: 1
Select item for more details and to access through your institution.
Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial
- Published in:
- Archives of Dermatological Research, 2020, v. 312, n. 6, p. 437, doi. 10.1007/s00403-019-02024-6
- By:
- Publication type:
- Article